Paoletti, A M <br/><br/>
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome.  [electronic resource] 

 -  Fertility and sterility  Oct 1996 
 - 527-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(16)58563-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Androgens--metabolism<br/>Cabergoline<br/>Dopamine Agonists--therapeutic use<br/>Double-Blind Method<br/>Ergolines--therapeutic use<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Luteinizing Hormone--blood<br/>Menstrual Cycle--drug effects<br/>Polycystic Ovary Syndrome--blood